1. Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf 2014; 5(6): 229–241.
2.
Salama AH. Study the activity of conjugated antimicrobial peptide WW-185 against clinically important bacteria. Pharmacia 2023; 70(2): 331–336.
3.
Al Mujaini SM, Almayahi ZK, Abouammoh NA, et al. Antibiotic prescription pattern among Primary Healthcare General Practitioners in the South Batinah Governorate of Oman, 2019. BMC Primary Care 2024; 25(1): 291.
4.
Essafi S, Letaief AO, Phillips E, et al. Antimicrobial stewardship and economic evaluation of urinary tract infection management in primary health care in Tunisia. Fam Med Prim Care Rev 2021; 23(3): 295–300.
5.
Yasein N, Shroukh W, Barghouti F, et al. The potential counter effect of COVID-19 outbreak on an antimicrobial agents prescribing educational intervention. J Infect Dev Ctries 2021; 15(11): 1653–1660.
6.
World Health Organization. Jordan’s national action plan on antimicrobial resistance launches under royal patronage, 2023 [cited 22.02.2024]. Available from URL: https://www.emro.who.int/jor/jordan-news/jordans-national-action-plan-on-antimicrobial-resistance-launches-under-royal-patronage.html.
7.
World Health Organization. The selection and use of essential medicines 2023. Executive summary of the report of the 24th WHO Expert Committee on the Selection and Use of Essential Medicines. 2023, Geneva: World Health Organization. Available from URL: https://iris.who.int/server/api/core/bitstreams/f8f65796-ca38-4bc3-9833-af6edf4f5669/content.
8.
Aqel AA, Al-Matarneh TM, Al-Tarawneh TK, et al. Monitoring of Antibiotic Resistance Patterns Within Al-Karak Governmental Hospital, Jordan, in 2022. Antibiotics 2024; 13(12): 1172.
9.
Song H, Liu X, Zouet K, et al. Assessment of antibiotic consumption patterns in hospital and primary healthcare using WHO Access, Watch and Reserve classification (AWaRe) in Sichuan Western China: 2020. Arch Public Health 2024; 82(1): 182.
10.
Abdu N, Idrisnur S, Tewelde T, et al. Antibiotic prescribing practice using WHO Access, Watch and Reserve classification and its determinants among outpatient prescriptions dispensed to elderly population in six community chain pharmacies in Asmara, Eritrea: a cross-sectional study. BMJ Open 2024; 14(6): e085743.
11.
Amaha ND, Weldemariam DG, Abdu N, et al. Prescribing practices using WHO prescribing indicators and factors associated with antibiotic prescribing in six community pharmacies in Asmara, Eritrea: a cross-sectional study. Antimicrob Resist Infect Control 2019; 8: 163.
12.
Ingelbeen B, Valia D, Phanzuet DM, et al. Setting a realistic AWaRe target for primary care antibiotic use in LMICs. Lancet Infect Dis 2023; 23(2): 152–153.
13.
Zhussupova G, Utepova D, Orazova G, et al. Evaluation of Antibiotic Use in Kazakhstan for the Period 2017–2019 Based on WHO Access, Watch and Reserve Classification (AWaRe 2019). Antibiotics (Basel) 2021; 10(1): 28.
14.
Alshareef H, Alanazi A, Alatawi N, et al. Assessment of antibiotic prescribing patterns at dental and primary health care clinics according to WHO Access, Watch, Reserve (AWaRe) classification. Am J Infect Control 2023; 51(3): 289–294.
15.
World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report 2022. Geneva: WHO; 2022.
16.
Roope LSJ, Smith RD, Pouwels KB, et al. The challenge of antimicrobial resistance: What economics can contribute. Science 2019; 364(6435): eaau4679.
17.
Sulis G, Sayood S, Gandra S. How can we tackle the overuse of antibiotics in low- and middle-income countries? Expert Rev Anti Infect Ther 2023; 21(11): 1189–1201.
18.
Zhu N, Aylin P, Rawson T, et al. Investigating the impact of COVID-19 on primary care antibiotic prescribing in North West London across two epidemic waves. Clin Microbiol Infect 2021; 27(5): 762–768.
19.
Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet 2013; 381(9868): 752–762.
20.
European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net) – Annual Epidemiological Report 2019. Available from URL: https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2019.
21.
Byarugaba DK, Osman TS, Sayyouh OM, et al. Genomic Epidemiology of Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae in Kenya, Uganda, and Jordan. Emerg Infect Dis 2024; 30(14): 33–40.
22.
Gharaibeh MH, Alyafawi DA, Elnasser ZA, et al. Emergence of mcr-1 gene and carbapenemase-encoding genes among colistin-resistant Klebsiella pneumoniae clinical isolates in Jordan. J Infect Public Health 2022; 15(8): 922–929.
